GSK-204706

Study Sponsor: GSK

Study Title

A single centre, single dose, open-label, randomized, 2-part, 2-way crossover study to determine the bioequivalence of levocetirizine oral disintegrating tablet given with water and without water compared to levocetirizine immediate release tablet in healthy Japanese male subjects

Medicine or Vaccine (generic name)

levocetirizine

Sponsor Identification Number

204706

Trial Registry Identification Number(#'s)

NCT03555890

Medical Condition

Rhinitis

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=204706

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03555890

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

April 2020